Skip to content

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Time Efficiency Comparison of Two Intravitreal Injection Techniques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04455399
Acronym
TIVI
Enrollment
200
Registered
2020-07-02
Start date
2020-11-09
Completion date
2021-01-09
Last updated
2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroidal Neovascularization, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion With Macular Edema, Uveitic Macular Edema

Keywords

intravitreal injection, intravitreal injecton guide, macular edema, time efficiency, anti-VEGF

Brief summary

Prospective, single-center, randomized, clinical trial (RCT) comparing the time efficiency and safety of a single-use intravitreal injection (IVI) guide versus a traditional technique using a dual blade speculum among patients undergoing IVI for various indications.

Detailed description

Prospective, single-center, randomized, clinical trial (RCT) comparing the efficiency and safety of a single-use IIG with a traditional technique using a dual blade speculum among patients undergoing IVI for various indications. The investigators will include eyes of adult patients scheduled to undergo unilateral IVI for neovascular age-related macular degeneration (nAMD), polypoidal choroidal vasculopathy (PCV), diabetic macular edema (DME), retinal vein occlusion (RVO), choroidal neovascular membrane from pathologic myopia (PM) and uveitis. The investigators will exclude eyes with a history of extraocular or intraocular infection within 3 months of the scheduled IVI date, scleral thinning, history of previous glaucoma surgery, history of pars plana vitrectomy, hypersensitity to the IVI drug, propracaine or povidone iodine, and inability to understand the informed consent form. The eyes will be randomly assigned in 1:1 fashion into two injection arms: intravitreal injection guide (IIG) and dual blade speculum (DBS). At the time of injection, a random number generator will be used to generate an odd or even number for each eye. Odd eyes will be assigned to IIG and even eyes will be assigned to DBS. For same day bilateral injection, once the first eye is randomized to one technique, the second eye will be automatically assigned to the other technique. The study will be conducted in compliance with the Declaration of Helsinki. All patients will provide informed consent prior to start of study procedures.

Interventions

DEVICEIntravitreal injection guide (Malosa)

A single use, multifunction device will be used to push away an eyelid to expose injection site, indicate injection point about 4 millimeters from surgical limbus, and directs needle perpendicular to the ocular surface while limiting intraocular needle incursion

DEVICEDual Blade Eyelid Speculum

A conventional dual blade eyelid speculum will be use to push away eyelids. A Castroviejo surgical caliper will be used to mark the injection site.

Sponsors

Peregrine Eye and Laser Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Intravitreal Injection Guide (Malosa, Beaver Visitec International, Waltham, MA)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\* Eyes of adult patients requiring intravitreally injected medications for non-infectious indications

Exclusion criteria

* History of extraocular or intraocular infection within 3 months of the scheduled IVI date * Scleral thinning * History of previous glaucoma surgery * History of pars plana vitrectomy * Hypersensitivity to the IVI drug, proparacaine or povidone iodine * Inability to understand the informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Duration of intravitreal injection procedureAt time of injection procedureDuration in seconds from application to removal of single-blade or dual blade speculum

Secondary

MeasureTime frameDescription
Adverse event rateImmediately and up to 1 month after the intravitreal injection procedureFrequency of adverse events and serious adverse events after intravitreal injection
Patient preference for IVI techniqueImmediately post injection using single-blade speculumPatient survey as to which technique is more comfortable and preferred among patients with prior injection experience using the dual blade speculum

Countries

Philippines

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026